资格:针对自体干细胞移植的多发性骨髓瘤患者的启动疗法。 Patients eligible at any stage of disease after assessment by L/BMT physician TESTS : CBC & D iff, electro lytes, urea, creatinine, total and direct bilirubin, alkaline phosphatase, AST, calcium, INR, PTT, SPE, quantitative immunoglobulins prior to chemotherapy Baseline (required, but results do not have to be available to proceed首次治疗必须在继续下一次治疗之前检查结果):HBSAG,HBSAB,HBCOREAB如果在临床上指示:HBV病毒载荷,ALT(请参阅协议SCHBV)预示:ondansetron 8 mg iv iv dexamethasone 8mg IV与NS 5mg IV乙型肝炎重新激活的中度至高风险。如果HbSAG或HBCOREAB阳性,请按照SCHBV遵循丙型肝炎预防。
基线:CBC&DIFF,血小板,肌酐,碱性磷酸酶,Alt,总胆红素,LDH,LDH,钠,钾,钾,TSH,TSH,早晨血清皮质醇,胸部X射线,胸部X射线基线必需的结果,必须进行首次治疗。 Before each treatment: CBC & Diff, platelets, creatinine, alkaline phosphatase, ALT, total bilirubin, LDH, sodium, potassium, TSH, creatine kinase, random glucose If clinically indicated: chest x-ray, morning serum cortisol, lipase, serum or urine HCG (required for women of child bearing potential if pregnancy suspected), free T3 and free T4,血清ACTH水平,睾丸激素,雌二醇,FSH,LH,ECG每周电话护理评估在治疗时(可选)时副作用的迹象和症状。预定:
基线:CBC&DIFF,血小板,肌酐,碱性磷酸酶,Alt,总胆红素,LDH,LDH,钠,钾,钾,TSH,TSH,早晨血清皮质醇,胸部胸部,胸部X-雷基线基础不需要以首次处理; 每次治疗前:CBC和DIFF,血小板,肌酐,碱性磷酸酶,Alt,总胆红素,LDH,LDH,钠,钾,TSH,TSH,肌酸激酶,随机葡萄糖,随机葡萄糖每周:CBC&DIFF,CBC&DIFF,CYCELS 1和2塞鲁斯六早上的血小板: HCG(如果怀疑怀孕,需要携带可能的儿童妇女),免费T3和游离T4,血清ACTH水平,睾丸激素,雌二醇,FSH,LH,ECG每周一次的电话护理评估副作用的迹象和症状在治疗时(可选)。预定:
测试:基线(首次治疗之前需要):CBC和DIFF,肌酐,总胆红素,ALT,碱性磷酸酶,钙,白蛋白,LDH,随机葡萄糖。如果女性的子轴承潜力(FCBP):通过定量β-HCG血液测试在初次处方前的7至14天24小时确认妊娠测试结果。 Baseline (required, but results do not have to be available to proceed with first treatment; results must be checked before proceeding with cycle 2): calcium, serum protein electrophoresis and serum free light chain levels, immunoglobulin panel (IgA, IgG, IgM), HCAb, HBsAg, HBsAb, HBcoreAb, TSH, beta-2 microglobulin Days 8, 15, 22 (如果前周期细胞质,高钙血症,肝或肾功能障碍或类固醇诱导的糖尿病,请进行可选。结果不必进行治疗。提供者要审查结果,没有针对中期循环血液调整的剂量修改):CBC和DIFF,肌酐,钠,钾,钾,总胆红素,ALT,ALT,ALT,碱性磷酸酶,钙,白蛋白,随机葡萄糖